Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junya Kanda

Showing results (61-70 of 422) with videos related to

Pageof 43
Sort By:
Clinical and Experimental Medicine|May 21, 2024
Utilizing red blood cell distribution width (RDW) as a reliable biomarker to predict treatment effects after chimeric antigen receptor T cell therapyNaokazu Nakamura, Tomoyasu Jo, Yasuyuki Arai, et al.
Transplantation and Cellular Therapy|January 28, 2024
Clinical Impact of Cytokine Release Syndrome on Prolonged Hematotoxicity after Chimeric Antigen Receptor T Cell Therapy: KyoTox A-Score, a Novel Prediction ModelNaokazu Nakamura, Tomoyasu Jo, Yasuyuki Arai, et al.
Bone Marrow Transplantation|May 2, 2022
Addition and drug monitoring of mycophenolate mofetil for GVHD prophylaxis in unrelated bone marrow transplantationFumiya Wada, Tadakazu Kondo, Ryusuke Yamamoto, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 13, 2019
Effect of the severity of acute graft-versus-host disease on physical function after allogeneic hematopoietic stem cell transplantationRyota Hamada, Tadakazu Kondo, Masanobu Murao, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 6, 2025
[Skin toxicities following auto PBSCT with thiotepa-based conditioning in adult patients: a single-center retrospective analysis]Tomomi Oka, Momoko Nishikori, Hiroyuki Irie, et al.
Cancer Medicine|December 2, 2016
High pretransplant hepcidin levels are associated with poor overall survival and delayed platelet engraftment after allogeneic hematopoietic stem cell transplantationSoichiro Sakamoto, Hiroshi Kawabata, Junya Kanda, et al.
Cytotherapy|July 1, 2025
Yield-driven approach optimizes apheresis of CD19 chimeric antigen receptor-T cell therapy for patients with lymphomaTomoyasu Jo, Toshio Kitawaki, Takashi Sakamoto, et al.
Bone Marrow Transplantation|December 19, 2023
KyoTox-e score; prediction of post-CAR-T prolonged thrombocytopenia using peripheral blood data before apheresisTomoyasu Jo, Yasuyuki Arai, Toshio Kitawaki, et al.
Scientific Reports|November 5, 2022
T-cell counts in peripheral blood at leukapheresis predict responses to subsequent CAR-T cell therapyFumiya Wada, Tomoyasu Jo, Yasuyuki Arai, et al.
British Journal of Clinical Pharmacology|May 10, 2020
Drug monitoring for mycophenolic acid in graft-vs-host disease prophylaxis in cord blood transplantationHiroyuki Muranushi, Junya Kanda, Yasuyuki Arai, et al.
Pageof 43

Showing results (61-70 of 422) with videos related to

Sort By:
Pageof 43
Clinical and Experimental Medicine|May 21, 2024
Utilizing red blood cell distribution width (RDW) as a reliable biomarker to predict treatment effects after chimeric antigen receptor T cell therapyNaokazu Nakamura, Tomoyasu Jo, Yasuyuki Arai, et al.
Transplantation and Cellular Therapy|January 28, 2024
Clinical Impact of Cytokine Release Syndrome on Prolonged Hematotoxicity after Chimeric Antigen Receptor T Cell Therapy: KyoTox A-Score, a Novel Prediction ModelNaokazu Nakamura, Tomoyasu Jo, Yasuyuki Arai, et al.
Bone Marrow Transplantation|May 2, 2022
Addition and drug monitoring of mycophenolate mofetil for GVHD prophylaxis in unrelated bone marrow transplantationFumiya Wada, Tadakazu Kondo, Ryusuke Yamamoto, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 13, 2019
Effect of the severity of acute graft-versus-host disease on physical function after allogeneic hematopoietic stem cell transplantationRyota Hamada, Tadakazu Kondo, Masanobu Murao, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 6, 2025
[Skin toxicities following auto PBSCT with thiotepa-based conditioning in adult patients: a single-center retrospective analysis]Tomomi Oka, Momoko Nishikori, Hiroyuki Irie, et al.
Cancer Medicine|December 2, 2016
High pretransplant hepcidin levels are associated with poor overall survival and delayed platelet engraftment after allogeneic hematopoietic stem cell transplantationSoichiro Sakamoto, Hiroshi Kawabata, Junya Kanda, et al.
Cytotherapy|July 1, 2025
Yield-driven approach optimizes apheresis of CD19 chimeric antigen receptor-T cell therapy for patients with lymphomaTomoyasu Jo, Toshio Kitawaki, Takashi Sakamoto, et al.
Bone Marrow Transplantation|December 19, 2023
KyoTox-e score; prediction of post-CAR-T prolonged thrombocytopenia using peripheral blood data before apheresisTomoyasu Jo, Yasuyuki Arai, Toshio Kitawaki, et al.
Scientific Reports|November 5, 2022
T-cell counts in peripheral blood at leukapheresis predict responses to subsequent CAR-T cell therapyFumiya Wada, Tomoyasu Jo, Yasuyuki Arai, et al.
British Journal of Clinical Pharmacology|May 10, 2020
Drug monitoring for mycophenolic acid in graft-vs-host disease prophylaxis in cord blood transplantationHiroyuki Muranushi, Junya Kanda, Yasuyuki Arai, et al.
Pageof 43